Amylyx Pharmaceuticals (AMLX) SEC Filings & 10K Form

$1.84
-0.09 (-4.40%)
(As of 03:34 PM ET)

Recent Amylyx Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/24/2024
6:12 AM
Amylyx Pharmaceuticals (Filer)
Form DEFA14A
04/24/2024
6:19 AM
Amylyx Pharmaceuticals (Filer)
Form ARS
04/24/2024
6:07 AM
Amylyx Pharmaceuticals (Filer)
Form DEF 14A
04/18/2024
7:19 PM
Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
7:20 PM
Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
7:20 PM
Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
7:21 PM
Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
7:23 PM
Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
8:19 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
6:10 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
3:31 PM
Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/15/2024
3:35 PM
Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
8:18 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:44 AM
Amylyx Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
Form SC 13G
03/08/2024
6:10 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
5:44 PM
Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
5:13 PM
Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
5:20 PM
Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
5:22 PM
Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:22 AM
Amylyx Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
6:08 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:36 PM
Amylyx Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2024
9:24 AM
Amylyx Pharmaceuticals (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
02/14/2024
6:15 AM
Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
01/29/2024
4:25 PM
Amylyx Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G
01/29/2024
3:38 PM
Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:50 PM
Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:04 PM
Amylyx Pharmaceuticals (Issuer)
Yeramian Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:10 PM
Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:11 PM
Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:11 PM
Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
3:37 PM
Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
6:00 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2023
3:45 PM
Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/29/2023
3:49 PM
Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
7:20 PM
Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
5:58 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:07 AM
Amylyx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
2:33 PM
Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2023
4:20 PM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
3:19 PM
Amylyx Pharmaceuticals (Subject)
Morningside Venture Investments Ltd (Filed by)
Form SC 13D/A
Did You Get Your Free Bitcoin Yet? (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here
08/24/2023
3:15 PM
Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
4:34 PM
Amylyx Pharmaceuticals (Issuer)
Morningside Venture Investments Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
4:15 PM
Amylyx Pharmaceuticals (Subject)
Morningside Venture Investments Ltd (Filed by)
Form SC 13D/A
08/17/2023
3:35 PM
Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2023
3:20 PM
Amylyx Pharmaceuticals (Issuer)
Olinger Margaret (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:16 PM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
6:50 PM
Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
6:39 PM
Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
6:46 PM
Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
6:34 PM
Amylyx Pharmaceuticals (Issuer)
FONTEYNE PAUL R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
7:14 AM
Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2023
3:38 PM
Amylyx Pharmaceuticals (Issuer)
Olinger Margaret (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
7:54 PM
Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AMLX) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners